Managing Director and Senior Biotechnology Analyst

Elemer Piros, Ph.D., is a Managing Director and Senior Biotechnology Analyst. Prior to joining Rodman, Dr. Piros was a Buyside Biotechnology Analyst at Spear, Leeds & Kellogg, now a wholly owned subsidiary of Goldman Sachs. From 1990 to 2000, Dr. Piros conducted academic research in the field of neuroscience focusing on understanding the molecular mechanism of communication in the nervous system. Dr. Piros earned degrees in mathematics and in biology and a Ph.D. in neuroscience at the University of California at Los Angeles. He then completed post-doctoral training at Cornell University Medical College in New York.

Dr. Piros has been ranked # 1 among biotechnology analysts in The Wall Street Journal’s annual “Best on the Street” survey in 2007.

Currently, Dr. Piros’ research universe includes emerging biotechnology companies that develop products addressing the nervous system and cancer.